Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on the tape, currently trading at $62.59, up from yesterday’s close by 0.24%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Merck & Co., Inc. (MRK) currently trades with a market capitalization of $168.68 Billion. That value represents a market adjusting for revenues that have been growing by 6.39 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of $5.32 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.03 on a per share basis this quarter. Perhaps, that suggests something about why 0.11% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how MRK has been acting. Looking at the stock’s movement on the chart, Merck & Co., Inc. recorded a 52-week high of $66.41. It is now trading 3.82% off that level. The stock is trading $58.89 its 50-day moving average by -3.7%. The stock carved out a 52-week low down at $52.83.
In recent action, Merck & Co., Inc. (MRK) has made a move of +5.73% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.57, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.74% with $2.69 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of MRK.